Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. USO
7. TLT
8. AMZN
9. META
10. LMT

Go back to Novavax to Receive up to $388 Million Funding from CEPI for COVID-19 Vaccine Development and Manufacturing
Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.00 +0.65 (6.95%)
Previous Close $9.35    52 Week High $9.23 
Open $9.62    52 Week Low $1.16 
Day High $10.38    P/E N/A 
Day Low $9.61    EPS $-0.30 
Volume 7,345,252       

Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.00 +0.65 (6.95%)
Previous Close $9.35    52 Week High $9.23 
Open $9.62    52 Week Low $1.16 
Day High $10.38    P/E N/A 
Day Low $9.61    EPS $-0.30 
Volume 7,345,252